142 related articles for article (PubMed ID: 27489147)
1. Testosterone Deficiency and Bone Metabolism Damage in Testicular Cancer Survivors.
Ondrusova M; Spanikova B; Sevcikova K; Ondrus D
Am J Mens Health; 2018 May; 12(3):628-633. PubMed ID: 27489147
[TBL] [Abstract][Full Text] [Related]
2. Damage of hormonal function and bone metabolism in long-term survivors of testicular cancer.
Ondrusova M; Ondrus D; Dusek L; Spanikova B
Neoplasma; 2009; 56(6):473-9. PubMed ID: 19728753
[TBL] [Abstract][Full Text] [Related]
3. Genetic variations associated with the effect of testicular cancer treatment on gonadal hormones.
Aschim EL; Oldenburg J; Kristiansen W; Giwercman A; Witczak O; Fosså SD; Haugen TB
Hum Reprod; 2014 Dec; 29(12):2844-51. PubMed ID: 25336703
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal Changes in Serum Levels of Testosterone and Luteinizing Hormone in Testicular Cancer Patients after Orchiectomy Alone or Bleomycin, Etoposide, and Cisplatin.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Kier MGG; Mortensen MS; Daugaard G
Eur Urol Focus; 2018 Jul; 4(4):591-598. PubMed ID: 28753832
[TBL] [Abstract][Full Text] [Related]
5. Fertility, gonadal and sexual function in survivors of testicular cancer.
Huddart RA; Norman A; Moynihan C; Horwich A; Parker C; Nicholls E; Dearnaley DP
Br J Cancer; 2005 Jul; 93(2):200-7. PubMed ID: 15999104
[TBL] [Abstract][Full Text] [Related]
6. Effect of 12-months testosterone replacement therapy on bone mineral density and markers of bone turnover in testicular cancer survivors - results from a randomized double-blind trial.
Jørgensen PL; Kreiberg M; Jørgensen N; Juul A; Oturai PS; Dehlendorff C; Lauritsen J; Wagner T; Rosenvilde J; Daugaard G; Medici CR; Jørgensen NR; Bandak M
Acta Oncol; 2023 Jul; 62(7):689-695. PubMed ID: 37151105
[TBL] [Abstract][Full Text] [Related]
7. Effect of chemotherapy on skeletal health in male survivors from testicular cancer and lymphoma.
Brown JE; Ellis SP; Silcocks P; Blumsohn A; Gutcher SA; Radstone C; Hancock BW; Hatton MQ; Coleman RE
Clin Cancer Res; 2006 Nov; 12(21):6480-6. PubMed ID: 17085662
[TBL] [Abstract][Full Text] [Related]
8. Sexual Function and Quality of Life in a National Cohort of Survivors of Bilateral Testicular Cancer.
Bandak M; Lauritsen J; Johansen C; Kreiberg M; Skøtt JW; Agerbaek M; Holm NV; Daugaard G
Eur Urol Focus; 2020 Jul; 6(4):711-719. PubMed ID: 30482585
[TBL] [Abstract][Full Text] [Related]
9. Risk of low bone mineral density in testicular germ cell cancer survivors: association with hypogonadism and treatment modality.
Isaksson S; Bogefors K; Åkesson K; Egund L; Bobjer J; Leijonhufvud I; Giwercman A
Andrology; 2017 Sep; 5(5):898-904. PubMed ID: 28591464
[TBL] [Abstract][Full Text] [Related]
10. Quality of Life in Long-Term Testicular Cancer Survivors With Compensated Leydig Cell Dysfunction.
Skøtt JW; Lauritsen J; Kreiberg M; Daugaard G; Bandak M
Clin Genitourin Cancer; 2019 Feb; 17(1):e65-e71. PubMed ID: 30293923
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal serum testosterone, luteinizing hormone, and follicle-stimulating hormone levels in a population-based sample of long-term testicular cancer survivors.
Sprauten M; Brydøy M; Haugnes HS; Cvancarova M; Bjøro T; Bjerner J; Fosså SD; Oldenburg J
J Clin Oncol; 2014 Feb; 32(6):571-8. PubMed ID: 24419125
[TBL] [Abstract][Full Text] [Related]
12. Leydig cell dysfunction, systemic inflammation and metabolic syndrome in long-term testicular cancer survivors.
Bandak M; Jørgensen N; Juul A; Lauritsen J; Oturai PS; Mortensen J; Hojman P; Helge JW; Daugaard G
Eur J Cancer; 2017 Oct; 84():9-17. PubMed ID: 28772110
[TBL] [Abstract][Full Text] [Related]
13. Testosterone deficiency in testicular cancer survivors - a systematic review and meta-analysis.
Bandak M; Jørgensen N; Juul A; Vogelius IR; Lauritsen J; Kier MG; Mortensen MS; Glovinski P; Daugaard G
Andrology; 2016 May; 4(3):382-8. PubMed ID: 27009402
[TBL] [Abstract][Full Text] [Related]
14. The metabolic syndrome and disturbances in hormone levels in long-term survivors of disseminated testicular cancer.
Nuver J; Smit AJ; Wolffenbuttel BH; Sluiter WJ; Hoekstra HJ; Sleijfer DT; Gietema JA
J Clin Oncol; 2005 Jun; 23(16):3718-25. PubMed ID: 15738540
[TBL] [Abstract][Full Text] [Related]
15. Altered bone status in unilateral testicular cancer survivors: Role of CYP2R1 and its luteinizing hormone-dependency.
Foresta C; Selice R; De Toni L; Di Mambro A; Carraro U; Plebani M; Garolla A
J Endocrinol Invest; 2013 Jun; 36(6):379-84. PubMed ID: 23047203
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular risk factors and morbidity in long-term survivors of testicular cancer: a 20-year follow-up study.
Haugnes HS; Wethal T; Aass N; Dahl O; Klepp O; Langberg CW; Wilsgaard T; Bremnes RM; Fosså SD
J Clin Oncol; 2010 Oct; 28(30):4649-57. PubMed ID: 20855830
[TBL] [Abstract][Full Text] [Related]
17. Associations between long-term serum platinum and neurotoxicity and ototoxicity, endocrine gonadal function, and cardiovascular disease in testicular cancer survivors.
Hjelle LV; Bremnes RM; Gundersen POM; Sprauten M; Brydøy M; Tandstad T; Wilsgaard T; Fosså SD; Oldenburg J; Haugnes HS
Urol Oncol; 2016 Nov; 34(11):487.e13-487.e20. PubMed ID: 27523611
[TBL] [Abstract][Full Text] [Related]
18. The assessment of testosterone and radioisotopic index of bone metabolism and bone mineral density in men with testosterone deficiency after one year of testosterone therapy.
Tryniszewski W; Kamiński G; Maziarz Z; Nowak M; Gadzicki M; Radek M
Nucl Med Rev Cent East Eur; 2018; 21(1):14-19. PubMed ID: 29319133
[TBL] [Abstract][Full Text] [Related]
19. Vitamin D status among long-term survivors of testicular cancer.
Schepisi G; De Padova S; Scarpi E; Lolli C; Gurioli G; Menna C; Burgio SL; Rossi L; Gallà V; Casadio V; Salvi S; Conteduca V; De Giorgi U
Oncotarget; 2017 May; 8(22):36780-36786. PubMed ID: 28030821
[TBL] [Abstract][Full Text] [Related]
20. Gonadal status in male survivors following childhood brain tumors.
Schmiegelow M; Lassen S; Poulsen HS; Schmiegelow K; Hertz H; Andersson AM; Skakkebaek NE; Müller J
J Clin Endocrinol Metab; 2001 Jun; 86(6):2446-52. PubMed ID: 11397837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
